Inactive Instrument
DIAL BIORFD Share Price Nasdaq Stockholm
Stocks
DIABIO BTA
SE0019173832
Biotechnology & Medical Research
| 1 day | +2.99% |
| Manager | Title | Age | Since |
|---|---|---|---|
Karin Wehlin
CEO | Chief Executive Officer | - | 23/11/2023 |
Fata Mrsic
DFI | Director of Finance/CFO | - | 14/06/2024 |
Emelie Danefur
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 41 | 01/01/2021 | |
| Chairman | 70 | 01/01/2021 | |
Kushagr Punyani
BRD | Director/Board Member | 35 | 01/01/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.99% | +15.00% | - | - | 7L | |
| -4.86% | -6.88% | -2.45% | +11.51% | 4.85TCr | |
| +0.70% | -0.27% | +380.66% | +609.14% | 3.9TCr | |
| +1.19% | +3.59% | +9.08% | +65.15% | 3.54TCr | |
| -1.06% | -3.81% | +6.16% | -12.81% | 3.37TCr | |
| -0.87% | -1.56% | -1.43% | +29.16% | 2.66TCr | |
| -0.65% | -5.72% | - | - | 1.68TCr | |
| +0.05% | +0.90% | +11.78% | +116.25% | 1.52TCr | |
| +1.38% | +1.90% | +11.46% | +15.39% | 1.39TCr | |
| -0.61% | -3.79% | +2.51% | -31.76% | 1.28TCr | |
| Average | -0.21% | -1.21% | +52.22% | +100.25% | 2.69TCr | |
| Weighted average by Cap. | -0.97% | -1.28% | +69.24% | +126.78% |
Employees
4
